Los Angeles Capital Management LLC Meridian Bioscience Inc Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$23.75 - $31.69 $843,053 - $1.12 Million	-35,497 Reduced 68.88%	16,034 $488,000
Q1 2022 May 06, 2022	SELL	$19.97 - $26.94 $134,597 - $181,575	-6,740 Reduced 11.57%	51,531 $1.34 Million
Q4 2021 Feb 03, 2022	SELL	$17.46 - $21.61 $694,733 - $859,861	-39,790 Reduced 40.58%	58,271 $1.19 Million
Q3 2021 Nov 08, 2021	SELL	$17.35 - $22.5 $85,691 - $111,127	-4,939 Reduced 4.8%	98,061 $1.89 Million
Q2 2021 Aug 05, 2021	BUY	$18.01 - $28.32 $918,978 - $1.45 Million	51,026 Added 98.18%	103,000 $2.29 Million
Q1 2021 May 05, 2021	BUY	$19.76 - $29.89 $153,317 - $231,916	7,759 Added 17.55%	51,974 $1.36 Million
Q4 2020 Feb 04, 2021	SELL	$15.73 - $21.66 $44,673 - $61,514	-2,840 Reduced 6.04%	44,215 $826,000
Q3 2020 Nov 02, 2020	SELL	$13.54 - $26.41 $638,289 - $1.24 Million	-47,141 Reduced 50.05%	47,055 $799,000
Q2 2020 Aug 05, 2020	BUY	$7.84 - $23.29 $157,403 - $467,593	20,077 Added 27.09%	94,196 $2.19 Million
Q1 2020 May 04, 2020	BUY	$5.57 - $11.5 $412,842 - $852,368	74,119 New	74,119 $623,000
Q2 2019 Jul 29, 2019	SELL	$10.88 - $17.6 $954,339 - $1.54 Million	-87,715 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$15.51 - $17.61 $1.63 Million - $1.85 Million	-104,990 Reduced 54.48%	87,715 $1.55 Million
Q4 2018 Feb 11, 2019	BUY	$14.52 - $19.72 $1.05 Million - $1.42 Million	72,036 Added 59.7%	192,705 $3.35 Million
Q3 2018 Nov 05, 2018	BUY	$14.85 - $16.35 $548,737 - $604,165	36,952 Added 44.14%	120,669 $1.8 Million
Q1 2018 Apr 27, 2018	SELL	$13.8 - $16.2 $703,731 - $826,119	-50,995 Reduced 37.85%	83,717 $1.19 Million
Q4 2017 Feb 05, 2018	BUY	$13.55 - $15.8 $641,064 - $747,513	47,311 Added 54.13%	134,712 $1.89 Million
Q3 2017 Nov 06, 2017	BUY	$13.45 - $14.35 $418,833 - $446,859	31,140 Added 55.35%	87,401 $1.25 Million
Q2 2017 Aug 09, 2017	BUY	N/A	56,261	56,261 $886,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account